MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

MediWound (NASDAQ:MDWD) stock climbed 4% following news that the company has initiated a Phase 3 study of its wound care product EscharEX in the treatment of venous leg ulcers, or VLU. The company ...

The addition of Marion General means the Lifeline of Ohio Placenta Donation Program will be available at all OhioHealth ...

As home health providers increasingly serve people with more complicated and serious conditions, and the push for ...

Matthew Valentine held the TCA boys basketball career scoring record for 23 years. Brayden Waller broke it recently, and ...

Alcohol-related deaths increased 18% during the pandemic, as did hospitalizations related to alcohol use, according to new ...

What is a pressure ulcer or bedsore? A pressure ulcer, or bedsore, is an area of skin - and sometimes also the tissue underneath - that has become damaged because of pressure. An ulcer may develop ...